Dr. Rajaram Yadav brings extensive practical experience in the Indian business sector, following his retirement. He has played a pivotal role in spearheading the introduction of various products and concepts in the Indian pharmaceutical market. In 2022, Frons Pharma made its mark in the industry with just four products for adults and one for paediatrics. Frons Pharma and Life Sciences Private Limited has been growing at a rate of over 40% annually. A key factor behind this success is its zero-attrition rate, alongside the delivery of high-quality products and exceptional customer satisfaction within the pharma industry.